Jeff Evans has been editor of Rheumatology News/MDedge Rheumatology and the EULAR Congress News since 2013. He started at Frontline Medical Communications in 2001 and was a reporter for 8 years before serving as editor of Clinical Neurology News and World Neurology, and briefly as editor of GI & Hepatology News. He graduated cum laude from Cornell University (New York) with a BA in biological sciences, concentrating in neurobiology and behavior.
News
MS trial tracks patient-reported benefits of switching from an injectable to fingolimod
Key clinical point: Patients who switched from an injectable DMT reported greater treatment satisfaction and improvements in fatigue, depression,...
News
Increased risk of heart attack confirmed in Sjögren’s syndrome patients
Key clinical point: The findings support monitoring for coronary artery disease in patients with Sjögren’s syndrome in addition to management and...
News
Eteplirsen showed safety, efficacy over 2 years in Duchenne muscular dystrophy
Key clinical point: Treatment with eteplirsen stabilized key clinical features of DMD and had no significant adverse events over 2 years.Major...
News
Current smoking strongly predicts rheumatoid arthritis radiographic progression
Major finding: At 1 year, 63% of patients who were current smokers and had erosive disease and high CRP levels at baseline developed radiographic...
News
Novel mutations point to new genetic etiologies of Dravet syndrome
Major finding: New disease-causing mutations were detected in novel genes for Dravet syndrome, including mutations in GABRA1 in four cases and in...
News
Methotrexate alone or with etanercept have equal efficacy for early inflammatory arthritis
Major finding: Methotrexate plus etanercept or methotrexate plus placebo for 52 weeks led to similar rates of no tender or swollen joints in...
